CAS号:936623-90-4
品名:LCZ696
中文别名:LCZ696
英文别名:trisodium[3-((1S,3R)-1-biphenyl-4-ylmethyl-3-ethoxycarbonyl-1-butylcarbamoyl)propionate-(S)-3-methyl-2-(pentanoyl{2”-(tetrazol-5-ylate)biphenyl-4-ylmethyl}amino)butyrate]hemipentahydrate;trisodium3-((1S,3R)-1-(biphenyl-4-ylmethyl)-3-(ethoxycarbonyl)butylcarbamoyl)propionate(S)-3-methyl-2-(pentanoyl-(2-(tetrazol-1-at-5-yl)biphenyl-4'-ylmethyl)amino)butyratehemipentahydrate;Entresto;L-Valine,N-(1-oxopentyl)-N-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-,compd.withα-ethyl(αR,γS)-γ-[(3-carboxy-1-oxopropyl)amino]-α-methyl[1,1'-biphenyl]-4-pentanoate,sodiumsalt,hydrate(2:2:6:5);
分子式:C49H59N6Na3O8
分子量:928.997
精确质量:928.409
Psa:207.53
UNII号:WB8FT61183
MDL号:
简介:Valsartan/sacubitril(brandnameEntresto)isacombinationdrugforuseinheartfailuredevelopedbyNovartis.Itconsistsoftheangiotensinreceptorblockervalsartanandtheneprilysininhibitorsacubitril,ina1:1mixturebymoleculecount.ItmaybeusedinsteadofanACEinhibitororanangiotensionreceptorblockerinpeoplewithheartfailurewithreducedejectionfraction.